The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans

Clinical Immunology

Volumn 128, Issue 2, 2008, Pages 277-283

  Kim, Hyoun Ah ^a   Jeon, Ja Young ^a   Choi, Gil Soon ^a   Sung, Jun Mo ^a   Kim, Moo Jung ^a   Yun, Jeong Moon ^a   Suh, Chang Hee ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Antichromatin antibody; Diagnosis; Disease activity; Systemic lupus erythematosus

Indexed keywords

ANTIBODY; CHROMATIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY;

ADULT; ANTIBODY TITER; ARTHRITIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KOREA; LEUKOPENIA; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHROMATIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KOREA; LUPUS ERYTHEMATOSUS, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 46749126104     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.03.516     Document Type: Article

References (21)

1. Kotzin B.L. Systemic lupus erythematosus. Cell 85 (1996) 303-306
2. Tan E.M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44 (1989) 93-151
3. Wandstrat A.E., Carr-Johnson F., Branch V., Gray H., Fairhurst A.M., Reimold A., Karp D., Wakeland E.K., and Olsen N.J. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J. Autoimmun. 27 (2006) 153-160
4. Fritzler M.J., and Salazar M. Diversity and origin of rheumatologic autoantibodies. Clin. Microbiol. Rev. 4 (1991) 256-269
5. Mohan C., Adams S., Stanik V., and Datta S.K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177 (1993) 1367-1381
6. Amoura Z., Koutouzov S., and Piette J.C. The role of nucleosomes in lupus. Curr. Opin. Rheumatol. 12 (2000) 369-373
7. Amoura Z., Koutouzov S., Chabre H., Cacoub P., Amoura I., Musset L., Bach J.F., and Piette J.C. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum. 43 (2000) 76-84
8. Cairns A.P., McMillan S.A., Crockard A.D., Meenagh G.K., Duffy E.M., Armstrong D.J., and Bell A.L. Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann. Rheum. Dis. 62 (2003) 272-273
9. Min D.J., Kim S.J., Park S.H., Seo Y.I., Kang H.J., Kim W.U., Cho C.S., and Kim H.Y. Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin. Exp. Rheumatol. 20 (2002) 13-18
10. Cervera R., Vinas O., Ramos-Casals M., Font J., Garcia-Carrasco M., Siso A., Ramirez F., Machuca Y., Vives J., Ingelmo M., and Burlingame R.W. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann. Rheum. Dis. 62 (2003) 431-434
11. Gutierrez-Adrianzen O.A., Koutouzov S., Mota R.M., das Chagas Medeiros M.M., Bach J.F., and de Holanda Campos H. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies. J. Rheumatol. 33 (2006) 1538-1544
12. Swaak A.J., van de Brink H., Smeenk R.J., Manger K., Kalden J.R., Tosi S., Marchesoni A., Domljan Z., Rozman B., Logar D., Pokorny G., Kovacs L., Kovacs A., Vlachoyiannopoulos P.G., Moutsopoulos H.M., Chwalinska-Sadowska H., Dratwianka B., Kiss E., Cikes N., Anic B., Schneider M., Fischer R., Bombardieri S., Mosca M., Graninger W., and Smolen J.S. Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford) 40 (2001) 89-94
13. Ganczarczyk L., Urowitz M.B., and Gladman D.D. "Latent lupus". J. Rheumatol. 16 (1989) 475-478
14. Stahl Hallengren C., Nived O., and Sturfelt G. Outcome of incomplete systemic lupus erythematosus after 10 years. Lupus 13 (2004) 85-88
15. Vila L.M., Mayor A.M., Valentin A.H., Garcia-Soberal M., and Vila S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 9 (2000) 110-115
16. Emlen W., Holers V.M., Arend W.P., and Kotzin B. Regulation of nuclear antigen expression on the cell surface of human monocytes. J. Immunol. 148 (1992) 3042-3048
17. Su Y., Jia R.L., Han L., and Li Z.G. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus. Clin. Immunol. 122 (2007) 115-120
18. Simon J.A., Cabiedes J., Ortiz E., Alcocer-Varela J., and Sanchez-Guerrero J. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology (Oxford) 43 (2004) 220-224
19. Ng K.P., Manson J.J., Rahman A., and Isenberg D.A. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis Rheum. 55 (2006) 900-904
20. Burlingame R.W., Rubin R.L., Balderas R.S., and Theofilopoulos A.N. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91 (1993) 1687-1696
21. Morel L., Blenman K.R., Croker B.P., and Wakeland E.K. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1787-1792